相关期刊:《World Journal of Traditional Chinese Medicine》《China Medical Abstracts(Internal Medicine)》《Journal of Chinese Pharmaceutical Sciences》《临床与实验病理学杂志》更多>>
supported by the National Natural Science Foundation of China(No.82405167);the Shenzhen Science and Technology Program(Guangdong,China)(No.GJHZ20220913143005010);the fundamental research project of the Shenzhen Science and Technology Innovation Commission(No.20231120113324002 and No.RCBS20231211090635056).
Pancreatic cancer is one of the most lethal cancers worldwide and is characterized by a poor prognosis.1,2 Due to its aggressive nature and lack of early symptoms,most patients are diagnosed at an advanced stage,and c...
In Fig.1c,the representative Transwell images of DU145 and PC3 cells in the bufalin group appeared incorrectly due to the mishandling in manuscript preparation.All the authors agree on the correction of our negligence...
This work was supported by the grants from the National Natural Science Foundation of China(No.81803895);Shandong Province Natural Science Foundation(No.ZR2021YQ57);China Postdoctoral Science Foundation(Nos.2020M682131 and 2021T140357).
Intrahepatic cholangiocarcinoma(icC)accounts for approximately 15%of primary liver cancers,and the incidence rate has been increasing in recentyears.Surgical resection is the best treatment for IcC,but the 5-year surv...
Supported by the National Natural Science Foundation of China (No.81573654)。
Objective: To explore the effect and mechanism of action of bufalin in triple-negative breast cancer(TNBC) drug-resistant cell lines. Methods: The normal human mammary epithelial cell line, TNBC cell line, TNBC adriam...
Supported by grants from the Medical Guidance Project of Shanghai Science and Technology Commission(No.19401935200);the Budget Internal Medicine Research Project of Shanghai University of Traditional Chinese Medicine(No.2020LK065).
Objective Bufalin,the main active anti-tumor monomer of toad venom,is crucial in cancer treatment.However,intrinsic issues,such as poor solubility and systematic toxicity,have considerably mitigated its anticancer fun...
This study was supported by a grant from the Special project for central guidance of local science and technology development of Liaoning province(No.2019JH6/10400006)。
Background:Previous studies have shown that bufalin exerts antitumor effects through various mechanisms.This study aimed to determine the antineoplastic mechanism of bufalin,an extract of traditional Chinese medicine ...
Financial support from the National Natural Science Foundation of China (Nos. 31771099, 81871504, and31671025);Natural Science Foundation of Guangdong Province (No. 2020A1515011066);Pearl River S&T Nova Program of Guangzhou (No. 201806010170) are greatly acknowledged. The animal procedures were performed in according to the protocol approved by the Institutional Animal Care and Use Committee at Southern Medical University.
Bufalin is efficacious in treating various tumors, however, the clinical application of which is restricted by the myocardial toxicity. Developing a smart synergetic delivery system is widely considered as a promising...
financially supported by the National Natural Science Foundation of China (81673739);the National Key Research and Development Program of China (No.2018YFC1705305);Shanghai Development Office of Traditional Chinese Medicine (No. ZY[2018-2020]-FWTX-4010);Shanghai “13th Five-year Plan” Clinical Key Department—Department of Dermatology of Traditional Chinese Medicine (No. shslczdzk05001);Clinical Research Plan of SHDC (No.SHDC2020CR3097B)。
Objective: Bufalin is an effective drug for the treatment of liver cancer. But its high toxicity, poor watersolubility, fast metabolism and short elimination half-life limit its use in tumor treatment. How to make the...